A first-ever vaccine designed to deliver a one-two-three punch against the main causes of traveller's diarrhea worldwide may result from new research published by a University of Guelph chemist.
5
0
Sepsis remains a common and deadly condition that occurs when the body reacts to an infection in the bloodstream. Scientists know little about the early stages of the condition; however, physicians must act fast. Every hour ...
58
0
Clinical and research teams at Oxford University Hospitals (OUH) NHS Foundation Trust, using infection prevention and control best practice, whole genome sequencing and electronic patient data, have halted an outbreak of ...
81
0
Alterations to the respiratory microbiome have been identified as a predisposing factor of interstitial lung diseases (ILD). In a study at CHEST 2018, researchers at Beaumont Health Systems studied the influence of bacterial ...
0
0
A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research (DZIF) has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital ...
1
0
LSTM's Dr. Adam Roberts is a co-author on a new paper published in Nature Communications which reports conserved collateral susceptibility to antibiotics in the human pathogen Escherichia coli.
44
0
(HealthDay)—Though the incidence of tickborne infections in the United States has risen significantly within the past decade, prevention and management are hampered by inadequate diagnostics as well as a lack of treatment ...
0
0
There are more clinical phenotypes of severe malaria than those defined by the World Health Organization (WHO), according to a study led by ISGlobal. The results indicate that heart failure can be a pathogenic mechanism of ...
0
0
The use of mud or wet clay as a topical skin treatment, or poultice, is a common practice in many cultures. In fact, the concept of using mud as medicine goes back to the earliest times.
28
0
For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system's B cells from doing their normal job of fighting pathogens. This ...
115
0
